Chemoinformaics analysis of Lanosta-7,24-dien-3-one
| Molecular Weight | 440.712 | nRot | 4 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 22 |
| Exact Molecular Weight | 440.365 | nRing | 4 |
| Solubility: LogS | -6.105 | nHRing | 0 |
| Solubility: LogP | 7.105 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 83.7101 |
| nHD | 1 | BPOL | 49.0219 |
| QED | 0.459 |
| Synth | 4.818 |
| Natural Product Likeliness | 3.745 |
| NR-PPAR-gamma | 0.079 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.267 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.832 |
| MDCK | 0.00000927 |
| BBB | 0.987 |
| PPB | 0.99491 |
| VDSS | 1.536 |
| FU | 0.0230329 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.585 |
| CYP2c19-inh | 0.1 |
| CYP2c19-sub | 0.969 |
| CYP2c9-inh | 0.197 |
| CYP2c9-sub | 0.859 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.388 |
| CYP3a4-inh | 0.527 |
| CYP3a4-sub | 0.652 |
| CL | 19.701 |
| T12 | 0.024 |
| hERG | 0.005 |
| Ames | 0.013 |
| ROA | 0.375 |
| SkinSen | 0.013 |
| Carcinogencity | 0.133 |
| EI | 0.016 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.586 |
| Antiviral | No |
| Prediction | 0.647765 |